Henoch-Schönlein purpura (HSP) during treatment with anastrozole

Ann Oncol. 2007 Jan;18(1):205-207. doi: 10.1093/annonc/mdl350. Epub 2006 Oct 16.

Authors

M Conti-Beltraminelli¹, O Pagani², G Ballerini¹, A Richetti¹, R Graffeo¹, M Ruggeri¹, V Forni³, S Pianca³, C Schönholzer³, C Mainetti⁴, F Cavalli¹, A Goldhirsch¹

Affiliations

¹ Institute of Oncology of Southern Switzerland (IOSI), Ospedale Regionale Bellinzona e Valli, Switzerland.
² Institute of Oncology of Southern Switzerland (IOSI), Ospedale Regionale Bellinzona e Valli, Switzerland. Electronic address: olivia.pagani@ibcsg.org.
³ Division of Nephrology, Ospedale Regionale di Lugano.
⁴ Division of Dermatology, Ospedale Regionale Bellinzona e Valli, Switzerland.

PMID: 17043095
DOI: 10.1093/annonc/mdl350

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Anastrozole
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Aromatase Inhibitors / adverse effects*
Breast Neoplasms / complications
Breast Neoplasms / drug therapy*
Breast Neoplasms / secondary
Female
Humans
IgA Vasculitis / chemically induced*
IgA Vasculitis / pathology
Nitriles / adverse effects*
Triazoles / adverse effects*

Substances

Aromatase Inhibitors
Nitriles
Triazoles
Anastrozole